| 200 Verified Questions - 170 Questions with Answers
NSG 5140 Midterm Exam 2026-170 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive study resource for NSG 5140 Advanced Pathophysiology is meticulously curated
to align with the 2026/2027 academic year midterm exam blueprint. It features 200 verified questions
with correct answers, providing a robust review of core pathophysiological concepts essential for
advanced nursing practice. The document is designed to reinforce critical thinking and clinical
application, ensuring students are well-prepared for the rigors of the midterm examination.
Key Features:
Cellular adaptation and injury mechanisms
Inflammation and immune response pathology
Neoplastic transformation and cancer biology
Fluid, electrolyte, and acid-base imbalances
Genetic and epigenetic influences on disease
System-specific pathophysiology (cardiovascular, respiratory, renal, etc.)
Updates for 2026:
- Updated to reflect 2026/2027 course objectives and exam blueprint
- Incorporated latest evidence-based guidelines and diagnostic criteria
- Expanded rationales for correct and incorrect answer choices
- Added new questions on emerging pathophysiological concepts
- Revised to align with current advanced practice nursing competencies
Abstract:
This exam preparation document for NSG 5140 Advanced Pathophysiology is a definitive resource for graduate
nursing students seeking to master the complex mechanisms of human disease. The 200 questions are carefully
selected to mirror the depth and breadth of the midterm exam, covering fundamental topics such as cellular injury,
inflammation, neoplasia, and systemic pathophysiology. Each question is accompanied by a verified correct
answer and a detailed rationale that explains the underlying scientific principles, promoting a deep understanding
rather than rote memorization. The content is organized to facilitate systematic review, with clear delineation of
major content areas and their respective weights. This document not only serves as a practice tool but also as a
study guide that highlights high-yield concepts frequently tested in advanced pathophysiology courses. By
engaging with these questions, students can identify knowledge gaps, reinforce learning, and build confidence for
exam success. The 2026/2027 edition incorporates the latest research and clinical guidelines, ensuring relevance
and accuracy. It is an indispensable tool for achieving a top score and advancing clinical competence.
Keywords:
Advanced Pathophysiology, NSG 5140, Midterm Exam, Nursing Exam Prep, Pathophysiology Questions,
2026/2027, Verified Answers, Graded A+
Answer Format:
Each question is presented in a multiple-choice format followed by the correct answer and a comprehensive
rationale. The rationale explains why the correct answer is right and why the distractors are incorrect, reinforcing
key pathophysiological principles. Answers are clearly marked and formatted for easy self-assessment.
Compliance Checklist:
Aligned with 2026/2027 NSG 5140 course syllabus
Page 1
, Questions reflect current advanced practice nursing guidelines
Answers verified for accuracy by subject matter experts
Rationales provided for all correct and incorrect options
Content organized by major exam blueprint categories
Suitable for self-paced review and exam simulation
Content Area Overview:
Content Area Questions Key Topics Weight
Cellular Biology and Adaptation 1-25 Cell injury, adaptation, necrosis, apoptosis, 12.5%
autophagy
Inflammation and Immunity 26-50 Acute/chronic inflammation, immune 12.5%
response, hypersensitivity, autoimmunity
Neoplasia 51-70 Carcinogenesis, tumor biology, oncogenes, 10%
tumor suppressors
Fluid, Electrolyte, and 71-90 Fluid shifts, electrolyte imbalances, 10%
Acid-Base acid-base disorders
Genetic and Developmental 91-110 Mendelian inheritance, chromosomal 10%
Disorders disorders, epigenetic mechanisms
Cardiovascular Pathophysiology 111-140 Heart failure, ischemic heart disease, 15%
hypertension, arrhythmias
Respiratory Pathophysiology 141-160 COPD, asthma, pneumonia, pulmonary 10%
embolism, ARDS
Renal and Urinary 161-180 Acute kidney injury, chronic kidney disease, 10%
Pathophysiology glomerulonephritis, electrolyte handling
Neurological Pathophysiology 181-200 Stroke, seizures, neurodegenerative diseases, 10%
increased intracranial pressure
Page 2
,Q1. In the context of cellular adaptation, which molecular mechanism best explains
the transition from reversible hypertrophy to irreversible heart failure in chronic
pressure overload?
A. Upregulation of insulin-like growth factor 1 (IGF-1) signaling leading to sustained
protein synthesis
B. Activation of the fetal gene program including increased expression of atrial
natriuretic peptide (ANP)
C. Chronic activation of the calcineurin-NFAT pathway causing myocyte apoptosis and
fibrosis
D. Mitochondrial dysfunction and increased reactive oxygen species (ROS) production
triggering autophagy
Correct Answer: C. Chronic activation of the calcineurin-NFAT pathway causing
myocyte apoptosis and fibrosis
Rationale: The transition to heart failure involves maladaptive signaling pathways.
Chronic calcineurin-NFAT activation promotes myocyte apoptosis and fibrosis, leading to
irreversible remodeling. While IGF-1 and fetal gene program are adaptive initially, they
do not directly cause irreversible failure. Mitochondrial dysfunction contributes but is not
the primary switch.
Why Wrong:
A - IGF-1 signaling is generally adaptive and promotes hypertrophy without directly
causing irreversible failure.
B - Fetal gene program re-expression is an adaptive response, not a cause of
decompensation.
D - Mitochondrial dysfunction is a consequence rather than the primary trigger of the
transition.
Reference: McCance & Huether (2023). Pathophysiology: The Biologic Basis for Disease
in Adults and Children, 9th Ed., Ch. 3
Q2. A patient with sepsis develops acute kidney injury (AKI). Which
pathophysiological mechanism is most directly responsible for the early decline in
glomerular filtration rate (GFR)?
A. Tubular obstruction by casts and cellular debris
B. Afferent arteriolar vasoconstriction and reduced renal blood flow
C. Backleak of filtrate through damaged tubular epithelium
D. Increased renal interstitial pressure due to edema
Correct Answer: B. Afferent arteriolar vasoconstriction and reduced renal blood flow
Rationale: In sepsis, systemic vasodilation and release of vasoconstrictors (e.g.,
angiotensin II, norepinephrine) cause afferent arteriolar constriction, reducing renal
blood flow and GFR. Tubular obstruction and backleak occur later in established ATN.
Page 3
, Interstitial edema is a secondary phenomenon.
Why Wrong:
A - Tubular obstruction is a later feature of acute tubular necrosis, not the initial
cause.
C - Backleak occurs after tubular damage has already reduced GFR.
D - Interstitial edema is not the primary mechanism for early GFR decline.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 55
Q3. Which of the following best describes the role of the JAK-STAT pathway in the
pathophysiology of myeloproliferative neoplasms (MPNs) such as polycythemia vera?
A. It mediates the anti-apoptotic effects of thrombopoietin on megakaryocytes.
B. A gain-of-function mutation in JAK2 leads to constitutive activation of downstream
signaling, causing unchecked myeloid proliferation.
C. It suppresses erythropoietin receptor expression, leading to erythrocytosis.
D. It promotes the degradation of tumor suppressor proteins, enhancing leukemic
transformation.
Correct Answer: B. A gain-of-function mutation in JAK2 leads to constitutive
activation of downstream signaling, causing unchecked myeloid proliferation.
Rationale: The JAK2 V617F mutation is found in most MPNs, causing constitutive
activation of JAK-STAT signaling and cytokine-independent proliferation of myeloid
lineages. This is a key molecular mechanism. Other options describe unrelated or
incorrect functions.
Why Wrong:
A - Thrombopoietin signaling is not the central pathway in MPNs.
C - JAK-STAT activation typically increases, not suppresses, erythropoietin receptor
signaling.
D - JAK-STAT does not directly degrade tumor suppressors.
Reference: Kumar, Abbas, Aster (2024). Robbins & Cotran Pathologic Basis of Disease,
10th Ed., Ch. 13
Q4. A patient with chronic obstructive pulmonary disease (COPD) presents with
increased dyspnea and a widened alveolar-arterial (A-a) gradient. Which mechanism
is the most likely contributor to the widened A-a gradient?
A. Decreased inspired oxygen concentration
B. Ventilation-perfusion (V/Q) mismatch due to emphysematous destruction of alveolar
walls
C. Right-to-left cardiac shunt from patent foramen ovale
D. Hypoventilation leading to increased PaCO2
Correct Answer: B. Ventilation-perfusion (V/Q) mismatch due to emphysematous
Page 4